Procter & Gamble (PG) just reshuffled its leadership bench in India, promoting Shalini Saraswat to Brand Director and Business Head for Pantene India, placing new marketing oversight on a key emerging market hair care label.
For shareholders, the story around Procter & Gamble has been more about steady momentum than big swings. The share price is up 9.45% over the past month and 16.23% over 90 days, while the 1 year total shareholder return sits at 16.57% and the 5 year figure at 29.66%. This suggests that recent optimism has built on a longer period of measured gains.
Scan how Procter & Gamble compares with a curated 30 resilient stocks with low risk scores that also aims for steadier returns over time.
After that steady climb in Procter & Gamble’s share price, the market value now sits only slightly below analyst targets, while still showing a wider gap to some intrinsic estimates. Where does fair value really sit in that spread?
Most Popular Narrative: 56% Overvalued
On Simply Wall St, the most followed narrative for Procter & Gamble pegs fair value at $107.52 against a last close of $167.67, creating a wide gap that has caught investors' attention. According to andre_santos, an investor in the Simply Wall St Community who wrote the narrative, that spread comes from stress testing the business with multiple valuation models and Monte Carlo scenarios rather than relying on a single point estimate.
Before presenting you with a final and empty number, I will show you first my own assumptions, as well as the historical data and analyst projections that led to that. My real objective here is to write down my valuation thoughts and, hopefully, in the process learn and help you learn something new.
See why 33 investors see Procter & Gamble as 56% overvalued.
Result: Fair Value of $107.52 (OVERVALUED)
Still, Procter & Gamble’s overvaluation case could be tested if pricing power weakens in key categories or if valuation multiples compress from current levels.
Find out about the key risks to this Procter & Gamble narrative.
Another View On Procter & Gamble’s Valuation
The community narrative calls Procter & Gamble 56% overvalued at $167.67, yet the market is not pricing it like an outlier. On a P/E of 24.7x, PG trades below the peer average of 32.4x and under its own fair ratio estimate of 27.9x. This points to more balanced valuation risk than the narrative implies. If sentiment turns or sector pricing shifts, the gap may change for long term holders.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Plenty of opinions are already in the price, yet your takeaway on Procter & Gamble should come from seeing both sides of the ledger yourself. To weigh what concerns other investors and what they are optimistic about, start with the 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Procter & Gamble?
Do not stop your research with Procter & Gamble when there are other opportunities that might fit your goals even better.
- Target steadier compounding by checking a 30 resilient stocks with low risk scores that filters for resilience when conditions change.
- Hunt for quality at a discount through a 32 high quality undervalued stocks that highlights strong businesses trading below their assessed worth.
- Grow your income stream with a 6 dividend fortresses focused on higher yielding stocks that still aim to keep payouts supported.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com